|
Established in 1987 under the administrative umbrella
of the United Nations Industrial Development Organization
(UNIDO), the International Centre for Genetic Engineering
and Biotechnology (ICGEB) now operates as an independent
intergovernmental organization with 46 full member states
and 32 affiliated centres.
ICGEB's mandate is to provide state-of-the-art research
and training opportunities in the fields of biotechnology
and molecular biology, especially for scientists in
developing countries and countries with economies in
transition.
The Centre's dual laboratory facilities in Trieste
(where the directorate is located) and New Delhi emphasize
research and training in a broad range of fields related
to:
÷ Health
÷ Nutrition
÷ Industrial Production
Special areas of research within ICGEB include:
÷ Molecular biology studies aimed at providing
basic knowledge and new diagnostic, therapeutic and
preventive methods for genetic, infectious and degenerative
diseases. ICGEB pursues a host of innovative strategies
for the development of vaccines designed to more effectively
treat such infectious diseases as hepatitis and malaria.
÷ Laboratory studies related to genome manipulation
of plant varieties to better combat insects, salinity
and other stresses.
÷ Examination and assessments of international
codes for biosafety.
÷ Capacity building for risk assessment related
to the release of genetically modified organisms (GMOs).
÷ Participation in activities related to the
implementation of the Biological Weapons Convention
to ensure the peaceful use of biotechnology.
More than 300 staff scientists and administrative staff
work at ICGEB facilities in Trieste and New Delhi. Each
year, some 400 students participate in the Centre's
research and training activities. In addition, a network
of 32 affiliated centres located in ICGEB's member states
extend the Centre's global reach and help ensure that
its research and development initiatives address local
and regional concerns.
Pre-doctoral fellowships (up to four years), awarded
in collaboration with the International School for Advanced
Studies (SISSA) in Trieste and the Jawaharlal Nehru
University in New Delhi, as well as post-doctoral fellowships
(up to three years), provide comprehensive state-of-the-art
education and training in biotechnology.
Collaborative research programmes nurture North-South
and South-South partnerships, and ICGEBnet, a biocomputing
resource operated by the Centre, provides an invaluable
tool for the up-to-date distribution of genomic data
and analysis. More than 500 scientists have registered
for this service.
Genetic engineering may prove the most significant
scientific endeavor of the 21st century. The ability
to manipulate genomes has already shown enormous potential
in a broad range of fields of critical importance to
the global community, including public health and nutrition,
environmental protection and remediation, and industrial
development.
However, most of the benefits derived from genetically
engineered plants and recombinant DNA-based vaccines
and diagnostics have been restricted to developed countries.
A key issue lying at the heart of ICGEB's mandate is
how to make biotechnology research and development more
inclusive by extending the circle of research and development
to science and technology communities in the developing
world.
To advance this goal, ICGEB has focused on the critical
importance of capacity building and the need to transfer
knowledge and concrete skills among both scientists
and scientific institutions.
ICGEB's research and training activities are both theoretical
and practical in nature. The Centre takes particular
care to ensure that the findings derived from its research
and laboratory initiatives are shared with all member
states.
Those who participate in ICGEB research and training
activities not only benefit from the advice of experts
but enjoy prolonged assistance from the Centre after
they return home. The Centre views extended periods
of interaction between its scientific staff and visiting
scientists as a key to its success.
|